Riskpilot← Back to searchSign inGet full accessA-EJENDOM 2002 ApS
APSActiveCVR 26663164Universitetsparken 4Rental and operating of own or leased real estate · NACE 6820Est. 2002— employees
Revenue 2024
DKK 337K
-50% vs 2023
EBITDA margin
100.0%
-50% vs 2023
Equity ratio
7.0%
Financial strength
Net profit 2024
DKK -40K
-108% vs 2023
| Revenue | DKK 337K | -50% |
| EBITDA | DKK 337K | -50% |
| Net profit | DKK -40K | -108% |
| Total assets | DKK 13M | +34% |
| Equity | DKK 918K | -36% |
| Employees | — | — |
Legal name
A-EJENDOM 2002 ApS
CVR number
26663164
Legal form
Anpartsselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
22. maj 2002
Share capital
DKK 250.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening.
Company purpose
Selskabets formål er at administrere ejendommen matr.nr. 12-m Nymarken. Himmelev.
Address
Universitetsparken 4
Phone
+4543435911
Email
urr@astma-allergi.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 828 | 828 | 828 | 828 | 828 | 828 | 828 | 688 | 698 | 693 | 675 | 673 | 337 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 1.507 | 846 | 509 | 681 | 688 | 676 | 684 | 688 | 698 | 693 | 675 | 673 | 337 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -47 |
| EBIT | 1.507 | 846 | 509 | 681 | 688 | 676 | 684 | 688 | 698 | 693 | 675 | 673 | 290 |
| Net financials | -735 | -399 | -390 | -383 | -206 | -366 | -248 | -195 | -192 | -183 | -161 | -167 | -350 |
| Profit before tax | 771 | 447 | 119 | 307 | 481 | 310 | 436 | 494 | 505 | 510 | 513 | 506 | -60 |
| Tax | 193 | 70 | 26 | 63 | 61 | 10 | 17 | 6 | -42 | 7 | 6 | 13 | -20 |
| Net profit | 579 | 377 | 93 | 245 | 420 | 300 | 419 | 487 | 548 | 503 | 507 | 493 | -40 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10.900 | 11.140 | 11.260 | 10.961 | 10.208 | 9.703 | 10.002 | 9.603 | 9.603 | 9.603 | 9.603 | 9.736 | 13.025 |
| Equity | 774 | 1.151 | 1.244 | 1.488 | 903 | 1.001 | 1.156 | 1.284 | 1.368 | 1.395 | 1.422 | 1.430 | 918 |
| Long-term debt | 9.414 | 9.072 | 9.068 | 8.871 | 8.508 | 8.307 | 7.865 | 7.516 | 7.160 | 7.155 | 6.567 | 6.267 | 7.857 |
| Short-term debt | 477 | 612 | 618 | 208 | 649 | 241 | 814 | 629 | 943 | 914 | 1.469 | 1.881 | 4.111 |
| Total debt | 9.891 | 9.684 | 9.685 | 9.079 | 9.157 | 8.548 | 8.679 | 8.144 | 8.103 | 8.069 | 8.036 | 8.148 | 11.969 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
7.0%
This company
38.2%
Market median
-82% vs market
20122024
Return on equity
-4.3%
This company
18.4%
Market median
-123% vs market
20122024
Net profit margin
-11.9%
This company
8.1%
Market median
-247% vs market
20122024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20122024
Debt / equity
13.19×
This company
0.62×
Market median
-2027% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JB Management | Management | 2002 | — | — |
HC Management | Management | 2002 | — | — |
AH Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
TC Management | Management | 2002 | — | — |
KM Management | Management | 2002 | — | — |
MS Deputy | Deputy | 2021 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Astma-Allergi Danmark | Company | 100.0% | 100.0% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Astma-Allergi Danmark
A-EJENDOM 2002 ApS Board members of A-EJENDOM 2002 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Bo Mortensen | Management | 0 companies |
| Henrik Caprani Winkel | Management | 0 companies |
| Anne Holm Hansen | Chief Executive Officer | 0 companies |
| Thorkil Clement Kjær | Management | 0 companies |
| Kim Madsen | Management | 0 companies |
| Michael Stanley Nielsen | Deputy | 0 companies |